Programme A | |||||||||||||||
CCQ total change β | CCQ symptoms change β | CCQ functional state change β | CCQ mental state change β | Medical Research Council Dyspnoea change β | |||||||||||
Step 1 | Step 2 | Step 3 | Step 1 | Step 2 | Step 3 | Step 1 | Step 2 | Step 3 | Step 1 | Step 2 | Step 3 | Step 1 | Step 2 | Step 3 | |
1. Programme B | 0.25** | 0.22** | 0.22** | 0.22** | 0.20** | 0.21* | 0.18** | 0.15* | 0.15* | 0.15** | 0.12 | 0.11 | 0.00 | 0.02 | 0.00 |
Programme C | 0.13* | 0.12 | 0.10 | 0.28** | 0.27** | 0.25** | 0.12* | 0.11 | 0.09 | –0.35** | −0.37** | −0.34** | 0.01 | 0.01 | −0.03 |
2. Assessing Chronic Illness Care change | 0.10 | 0.10 | 0.07 | 0.06 | 0.10 | 0.10 | 0.05 | 0.05 | −0.05 | −0.03 | |||||
Medication (yes=1; no=0) | 0.04 | 0.05 | 0.06 | 0.07 | 0.04 | 0.05 | −0.03 | −0.04 | −0.02 | 0.03 | |||||
Information (yes=1; no=0) | −0.03 | −0.04 | −0.03 | −0.04 | −0.04 | −0.05 | 0.02 | 0.02 | 0.08 | 0.10 | |||||
Follow-up (yes=1; no=0) | −0.07 | −0.08 | −0.05 | −0.06 | −0.07 | −0.08 | −0.02 | −0.02 | −0.03 | −0.01 | |||||
3. Age | −0.06 | −0.01 | −0.09 | −0.05 | −0.02 | ||||||||||
Sex (male=1; female=0) | 0.04 | 0.00 | 0.04 | 0.07 | −0.20** | ||||||||||
Smoking status (yes=1; no=0) | 0.09 | 0.09 | 0.11 | −0.04 | 0.07 | ||||||||||
Lung function baseline | −0.02 | −0.04 | −0.01 | −0.01 | 0.13* | ||||||||||
ΔR2 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 | 0.00 | 0.01 | 0.01 | 0.06 | |||||
R2 | 0.05 | 0.07 | 0.09 | 0.07 | 0.09 | 0.09 | 0.03 | 0.04 | 0.07 | 0.19 | 0.19 | 0.20 | 0.00 | 0.01 | 0.07 |
Significant F change | 8.65 | 1.21 | 1.23 | 12.77 | 0.89 | 0.84 | 4.60 | 1.81 | 2.08 | 35.90 | 0.37 | 0.64 | 0.00 | 0.61 | 4.51 |
df1/df2 | 2/315 | 4/311 | 3/307 | 2/319 | 4/315 | 3/311 | 2/319 | 4/315 | 3/311 | 2/316 | 4/312 | 4/308 | 2/292 | 4/288 | 4/284 |
*p<0.05; **p<0.01 (two-tailed) pairwise.
CCQ, clinical chronic obstructive pulmonary disease questionnaire.